Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trial

IntroductionPain is a highly prevalent symptom in the hospital setting, but treatment options remain limited. Harnessing the placebo effect in an ethical manner could provide a new possibility to reduce pain in clinical practice. So called open-label placebos (OLP) have been shown to elicit signific...

Full description

Bibliographic Details
Main Authors: Matthijs de Leeuw, Mirjam Laager, Jens Gaab, Wilhelm Ruppen, Tobias Schneider
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1238878/full
_version_ 1797310517378809856
author Matthijs de Leeuw
Mirjam Laager
Jens Gaab
Wilhelm Ruppen
Tobias Schneider
author_facet Matthijs de Leeuw
Mirjam Laager
Jens Gaab
Wilhelm Ruppen
Tobias Schneider
author_sort Matthijs de Leeuw
collection DOAJ
description IntroductionPain is a highly prevalent symptom in the hospital setting, but treatment options remain limited. Harnessing the placebo effect in an ethical manner could provide a new possibility to reduce pain in clinical practice. So called open-label placebos (OLP) have been shown to elicit significant effects in reducing acute pain. But, before implementation, more knowledge concerning the properties of OLPs is needed. This study aims to assess the duration of analgesic effects from OLP and to determine the possibility of boosting such effects.Methods and analysisThis is the protocol of an ongoing (first patient enrolled in March 2023) single-site randomized trial investigating OLPs in two parts (i.e., substudies). In both parts, pain will be induced in healthy adults using an intradermal electrical stimulation model. Participants in Part 1 will have two study visits: An interventional visit with one OLP injection accompanied by an evidence-based treatment rationale and a control visit with no treatment. For Part 2, participants will be randomized into three groups: (1) A fixed-time “Booster” group including one single repetition of the OLP injection at a fixed time point, (2) an on-demand “Booster” group including one single repetition of the OLP injection on-demand, and (3) a control group who will receive just one OLP injection. Differences in pain ratings over time (using the Numeric Rating Scale) will be analyzed with several two-sample t-tests. The time point for a fixed-time “Booster” in Part 2 will be derived from Part 1 with additional statistical tools such as a broken-stick mixed-effect model.DiscussionThis study aims to further characterize the analgesic effects of OLPs. In doing so, it will provide valuable information needed for later implementation of OLPs in clinical practice, where they could play a role in multimodal analgesic concepts.Ethics and disseminationThe “Ethikkommission Nordwest- und Zentralschweiz” (BASEC 2023-00296) approved the study protocol. Results of the analysis will be submitted for publication in a peer-reviewed journal.Clinical Trial RegistrationThis study is registered at ClinicalTrials.gov (NCT05819476) and is listed in the Swiss National Registry at kofam.ch (SNCTP000005470).
first_indexed 2024-03-08T01:45:08Z
format Article
id doaj.art-50c75da3951c48379da103580b9de67e
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-08T01:45:08Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-50c75da3951c48379da103580b9de67e2024-02-14T13:02:30ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2024-02-011110.3389/fmed.2024.12388781238878Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trialMatthijs de Leeuw0Mirjam Laager1Jens Gaab2Wilhelm Ruppen3Tobias Schneider4Pain Unit, Clinic for Anesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, Basel, SwitzerlandDepartment of Clinical Research, University of Basel, Basel, SwitzerlandDivision of Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Basel, Basel, SwitzerlandPain Unit, Clinic for Anesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, Basel, SwitzerlandPain Unit, Clinic for Anesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, Basel, SwitzerlandIntroductionPain is a highly prevalent symptom in the hospital setting, but treatment options remain limited. Harnessing the placebo effect in an ethical manner could provide a new possibility to reduce pain in clinical practice. So called open-label placebos (OLP) have been shown to elicit significant effects in reducing acute pain. But, before implementation, more knowledge concerning the properties of OLPs is needed. This study aims to assess the duration of analgesic effects from OLP and to determine the possibility of boosting such effects.Methods and analysisThis is the protocol of an ongoing (first patient enrolled in March 2023) single-site randomized trial investigating OLPs in two parts (i.e., substudies). In both parts, pain will be induced in healthy adults using an intradermal electrical stimulation model. Participants in Part 1 will have two study visits: An interventional visit with one OLP injection accompanied by an evidence-based treatment rationale and a control visit with no treatment. For Part 2, participants will be randomized into three groups: (1) A fixed-time “Booster” group including one single repetition of the OLP injection at a fixed time point, (2) an on-demand “Booster” group including one single repetition of the OLP injection on-demand, and (3) a control group who will receive just one OLP injection. Differences in pain ratings over time (using the Numeric Rating Scale) will be analyzed with several two-sample t-tests. The time point for a fixed-time “Booster” in Part 2 will be derived from Part 1 with additional statistical tools such as a broken-stick mixed-effect model.DiscussionThis study aims to further characterize the analgesic effects of OLPs. In doing so, it will provide valuable information needed for later implementation of OLPs in clinical practice, where they could play a role in multimodal analgesic concepts.Ethics and disseminationThe “Ethikkommission Nordwest- und Zentralschweiz” (BASEC 2023-00296) approved the study protocol. Results of the analysis will be submitted for publication in a peer-reviewed journal.Clinical Trial RegistrationThis study is registered at ClinicalTrials.gov (NCT05819476) and is listed in the Swiss National Registry at kofam.ch (SNCTP000005470).https://www.frontiersin.org/articles/10.3389/fmed.2024.1238878/fullopen-label placeboboosterplacebo analgesiaacute painelectrically-evoked painhyperalgesia
spellingShingle Matthijs de Leeuw
Mirjam Laager
Jens Gaab
Wilhelm Ruppen
Tobias Schneider
Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trial
Frontiers in Medicine
open-label placebo
booster
placebo analgesia
acute pain
electrically-evoked pain
hyperalgesia
title Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trial
title_full Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trial
title_fullStr Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trial
title_full_unstemmed Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trial
title_short Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trial
title_sort boosting open label placebo effects in acute induced pain in healthy adults bolpap study study protocol of a randomized controlled trial
topic open-label placebo
booster
placebo analgesia
acute pain
electrically-evoked pain
hyperalgesia
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1238878/full
work_keys_str_mv AT matthijsdeleeuw boostingopenlabelplaceboeffectsinacuteinducedpaininhealthyadultsbolpapstudystudyprotocolofarandomizedcontrolledtrial
AT mirjamlaager boostingopenlabelplaceboeffectsinacuteinducedpaininhealthyadultsbolpapstudystudyprotocolofarandomizedcontrolledtrial
AT jensgaab boostingopenlabelplaceboeffectsinacuteinducedpaininhealthyadultsbolpapstudystudyprotocolofarandomizedcontrolledtrial
AT wilhelmruppen boostingopenlabelplaceboeffectsinacuteinducedpaininhealthyadultsbolpapstudystudyprotocolofarandomizedcontrolledtrial
AT tobiasschneider boostingopenlabelplaceboeffectsinacuteinducedpaininhealthyadultsbolpapstudystudyprotocolofarandomizedcontrolledtrial